瑞聲(02018.HK)獲聯交所批准分拆光學業務於內地上市
瑞聲科技(02018.HK)公布,正考慮建議分拆其透過誠瑞光學持有的光學業務於中國一家證券交易所獨立上市,並已接獲聯交所批准可進行建議分拆。
鑑於誠瑞光學現正籌備建議分拆及獨立上市,為符合中國境內上市審核要求及市場慣例,於10月31日,誠瑞光學、誠瑞光學控股股東及現有戰略投資者訂立終止協議以終止股東協議,股東協議將自終止協議日期起終止,而訂約各方同意已授予現有戰略投資者的所有未行使的股東權利將予終止,並自終止協議日期起不再有效。
同日,誠瑞光學控股股東與現有戰略投資者就終止協議訂立補充協議,據此,現有戰略投資者獲授予若干權利,包括優先認購權、投資者購股權(回購權)、反稀釋權、優先購買權、共同出售權、轉股限制及優先清算權。
目前,誠瑞光學由公司持有約80.38%股份。誠瑞光學主要從事研發、生產及銷售光學產品。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.